Whole Genome Oligonucleotide-Based Array Comparative Genomic Hybridization Analysis Identified Fibroblast Growth Factor 1 As a Prognostic Marker for Advanced-Stage Serous Ovarian Adenocarcinomas
J Clin Oncol Birrer et al. 16:2281
Publisher’s Note
The June 1, 2007 article by Birrer et al entitled, “Whole Genome Oligonucleotide-Based Array Comparative Genomic Hybridization Analysis Identified Fibroblast Growth Factor 1 As a Prognostic Marker for Advanced-Stage Serous Ovarian Adenocarcinomas” (J Clin Oncol 25:2281-2287, 2007) was published online May 30, 2007 with errors. The first author, Michael J. Birrer, and the second author, Michael E. Johnson, should have been acknowledged for equal contributions to this study. Figure 6 and Figure A1 (online only) were inadvertently switched and paired with the wrong figure legend. All corrections have been made as of June 20, 2007.
|
